Kathleen R. Cho, MD | oneFAPvoice

welcome to oneFAPvoice

- a positively charged Familial Adenomatous Polyposis community.
  • join today!
healthcare providers

Kathleen R. Cho, MD

Healthcare Provider
Peter A Ward Professor of Pathology
Department of Pathology
University of Michigan Medical School
Places : University of Michigan Health System Johns Hopkins Medicine

Dr. Cho earned her B.A. degree from Yale University and her M.D. from Vanderbilt University School of Medicine in 1980 and 1984, respectively. She performed her Anatomic Pathology residency at the Johns Hopkins Hospital in Baltimore, Maryland from 1984 to 1988, and served as Chief Resident in her final year. From 1988 to 1990, she simultaneously served as Clinical Fellow in the Johns Hopkins Department of Pathology and Research Fellow in the Molecular Genetics Laboratory of the Johns Hopkins Oncology Center (under the direction of Dr. Bert Vogelstein).

Dr. Cho’s clinical interests are in gynecological pathology and she is a practicing surgical pathologist with diagnostic expertise in this area. Her research is aimed at elucidating the genetic alterations that underlie development and progression of the common gynecological tumors (carcinomas of the ovary, endometrium and uterine cervix).

A major focus of her research group has been on cervical cancer, with an emphasis on the molecular mechanisms by which human papillomaviruses contribute to the development and/or progression of these tumors. Her group has previously demonstrated that HPV-infected cells have altered cell cycle regulation, including abrogation of the growth arrest that normally follows DNA damage. These findings suggest a model of cervical tumorigenesis in which HPV-infected cells are predisposed to the accumulation of somatic mutations in tumor suppressor genes and/or oncogenes that are required for malignant transformation. Additional ongoing studies are aimed at identifying and characterizing novel genes involved in cervical tumorigenesis. The ultimate goal is to contribute to the development of better strategies with which to diagnose, treat, and/or prevent gynecological malignancies.

expertly curated content related to this topic

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.